BH-P-RAiN

A Phase 1a/1b Open-Label, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of ROSE12 as a Single Agent and in Combination with Other Anti-tumor Agents in Patients with Locally Advanced or Metastatic Tumors